🚀 Proud moment for us at @ParisTxGroup !
We are delighted to share our new article showing the strong performance of #iBox across diverse cohorts, subpopulations, and clinical scenarios, published @BMJMedicine
A key contribution of this work is the development and validation of additional flexible iBox algorithms, designed to adapt to differences in data availability across transplant centers worldwide.
These findings further support iBox as a powerful tool for allograft risk stratification and clinical trial endpoint assessment, in the context of its ongoing @US_FDA qualification pathway.
Congratulations to all co-authors and collaborators who made this possible.
#KidneyTransplantation #Transplantation #Nephrology #ClinicalTrials #DigitalHealth #Biomarkers #iBox #PrecisionMedicine
bmjmedicine.bmj.com/content/bmjmed…
We are delighted to share our new article showing the strong performance of #iBox across diverse cohorts, subpopulations, and clinical scenarios, published @BMJMedicine
A key contribution of this work is the development and validation of additional flexible iBox algorithms, designed to adapt to differences in data availability across transplant centers worldwide.
These findings further support iBox as a powerful tool for allograft risk stratification and clinical trial endpoint assessment, in the context of its ongoing @US_FDA qualification pathway.
Congratulations to all co-authors and collaborators who made this possible.
#KidneyTransplantation #Transplantation #Nephrology #ClinicalTrials #DigitalHealth #Biomarkers #iBox #PrecisionMedicine
bmjmedicine.bmj.com/content/bmjmed…
